• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 E4 对 PHF-Tau 网络影响的研究。

A Study on PHF-Tau Network Effected by Apolipoprotein E4.

机构信息

School of Management Science and Engineering, Shandong Technology and Business University, Yantai, People's Republic of China.

School of Information Science and Engineering, Lanzhou University, Lanzhou, People's Republic of China.

出版信息

Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520971414. doi: 10.1177/1533317520971414.

DOI:10.1177/1533317520971414
PMID:33258666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10623995/
Abstract

Apolipoprotein E 4 Allele (APOE 4) is an important factors in Mild cognitive impairment (MCI) and Alzheimer's disease(AD). It plays a primary role in abnormal modification of aggregated Tau protein-paired helical filaments Tau (PHF-Tau). In this study, 143 subjects with PHF-Tau PET were divided into 2 groups (APOE 4 carriers and noncarriers). The measurements of the PHF-Tau network properties and resilient were calculated for 2 group networks respectively. APOE 4 carriers group showed significant differences in all the network properties in the results. We also found significant differences of betweenness centrality in some brain regions for APOE 4 carriers. Moreover, the APOE 4 carriers showed less resilient to targeted or random node failure. Our results indicated that the effects of APOE 4 may lead to abnormalities of PHF-Tau protein network. These findings may be particularly helpful in uncovering the pathophysiology underlying the cognitive dysfunction in MCI patients.

摘要

载脂蛋白 E4 等位基因(APOE4)是轻度认知障碍(MCI)和阿尔茨海默病(AD)的重要因素。它在 Tau 蛋白聚集的异常修饰中起着主要作用——双螺旋丝 Tau(PHF-Tau)。在这项研究中,143 名 PHF-Tau PET 患者被分为 2 组(APOE4 携带者和非携带者)。分别计算了 2 组网络的 PHF-Tau 网络特性和弹性的测量值。APOE4 携带者组在结果中的所有网络特性上均显示出显著差异。我们还发现,在一些脑区,APOE4 携带者的介数中心度存在显著差异。此外,APOE4 携带者对靶向或随机节点故障的弹性较小。我们的研究结果表明,APOE4 的影响可能导致 PHF-Tau 蛋白网络的异常。这些发现可能有助于揭示 MCI 患者认知功能障碍的病理生理学基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b45/10623995/02e4c4e0e9b1/10.1177_1533317520971414-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b45/10623995/4131908d2d10/10.1177_1533317520971414-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b45/10623995/8dd511f2325b/10.1177_1533317520971414-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b45/10623995/3accac065fbe/10.1177_1533317520971414-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b45/10623995/02e4c4e0e9b1/10.1177_1533317520971414-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b45/10623995/4131908d2d10/10.1177_1533317520971414-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b45/10623995/8dd511f2325b/10.1177_1533317520971414-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b45/10623995/3accac065fbe/10.1177_1533317520971414-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b45/10623995/02e4c4e0e9b1/10.1177_1533317520971414-fig4.jpg

相似文献

1
A Study on PHF-Tau Network Effected by Apolipoprotein E4.载脂蛋白 E4 对 PHF-Tau 网络影响的研究。
Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520971414. doi: 10.1177/1533317520971414.
2
The Influence of Cerebrospinal Fluid Abnormalities and APOE 4 on PHF-Tau Protein: Evidence From Voxel Analysis and Graph Theory.脑脊液异常和APOE 4对PHF-Tau蛋白的影响:来自体素分析和图论的证据
Front Aging Neurosci. 2019 Aug 8;11:208. doi: 10.3389/fnagi.2019.00208. eCollection 2019.
3
Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.阿尔茨海默病脑脊液生物标志物、APOE基因分型与主观认知下降、轻度认知障碍及阿尔茨海默病患者听觉言语学习任务之间的关联
J Alzheimers Dis. 2016 Jul 29;54(1):157-68. doi: 10.3233/JAD-160176.
4
The Role of Apolipoprotein E ε4 in Early and Late Mild Cognitive Impairment.载脂蛋白 E ε4 在早发性和晚发性轻度认知障碍中的作用。
Eur Neurol. 2021;84(6):472-480. doi: 10.1159/000516774. Epub 2021 Aug 2.
5
Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.在纵向随访的轻度认知障碍和阿尔茨海默病患者中,血浆载脂蛋白 E 水平。
Alzheimers Res Ther. 2022 Aug 24;14(1):115. doi: 10.1186/s13195-022-01058-9.
6
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.载脂蛋白 E ɛ4 等位基因与唐氏综合征成人阿尔茨海默病的临床和多模态生物标志物变化的关联。
JAMA Neurol. 2021 Aug 1;78(8):937-947. doi: 10.1001/jamaneurol.2021.1893.
7
Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals.性别会影响认知障碍个体中载脂蛋白 E ε4 剂量对脑 tau 沉积的影响。
Brain. 2021 Nov 29;144(10):3201-3211. doi: 10.1093/brain/awab160.
8
Association of APOE gene with longitudinal changes of CSF amyloid beta and tau levels in Alzheimer's disease: racial differences.载脂蛋白 E 基因与阿尔茨海默病患者脑脊液淀粉样蛋白β和 tau 水平纵向变化的关联:种族差异。
Neurol Sci. 2024 Mar;45(3):1041-1050. doi: 10.1007/s10072-023-07076-1. Epub 2023 Sep 28.
9
Sex modulates the ApoE ε4 effect on brain tau deposition measured by F-AV-1451 PET in individuals with mild cognitive impairment.性别调节载脂蛋白 E ε4 对轻度认知障碍个体脑 Tau 沉积的影响,通过 F-AV-1451 PET 进行测量。
Theranostics. 2019 Jul 9;9(17):4959-4970. doi: 10.7150/thno.35366. eCollection 2019.
10
APOE ε4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer's disease.在前驱性阿尔茨海默病中,APOE ε4与脑脊液中较高水平的SNAP-25相关。
Neurosci Lett. 2018 Oct 15;685:109-113. doi: 10.1016/j.neulet.2018.08.029. Epub 2018 Aug 23.

引用本文的文献

1
Brain Network Alterations in Rectal Cancer Survivors With Depression Tendency: Evaluation With Multimodal Magnetic Resonance Imaging.有抑郁倾向的直肠癌幸存者的脑网络改变:多模态磁共振成像评估
Front Neurol. 2022 Jun 29;13:791298. doi: 10.3389/fneur.2022.791298. eCollection 2022.
2
Liposome based drug delivery as a potential treatment option for Alzheimer's disease.基于脂质体的药物递送作为阿尔茨海默病的一种潜在治疗选择。
Neural Regen Res. 2022 Jun;17(6):1190-1198. doi: 10.4103/1673-5374.327328.

本文引用的文献

1
Learning Metabolic Brain Networks in MCI and AD by Robustness and Leave-One-Out Analysis: An FDG-PET Study.通过稳健性和留一法分析学习 MCI 和 AD 的代谢性脑网络:一项 FDG-PET 研究。
Am J Alzheimers Dis Other Demen. 2018 Feb;33(1):42-54. doi: 10.1177/1533317517731535. Epub 2017 Sep 21.
2
18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.18F-FDG PET 诊断和预后模式在轻度认知障碍(MCI)阶段的阿尔茨海默病(AD)患者中没有重叠。
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2073-2083. doi: 10.1007/s00259-017-3790-5. Epub 2017 Aug 7.
3
Global Efficiency of Structural Networks Mediates Cognitive Control in Mild Cognitive Impairment.
结构网络的全局效率介导轻度认知障碍中的认知控制。
Front Aging Neurosci. 2016 Dec 15;8:292. doi: 10.3389/fnagi.2016.00292. eCollection 2016.
4
Differences in Aβ brain networks in Alzheimer's disease and healthy controls.阿尔茨海默病与健康对照者大脑中β淀粉样蛋白网络的差异。
Brain Res. 2017 Jan 15;1655:77-89. doi: 10.1016/j.brainres.2016.11.019. Epub 2016 Nov 17.
5
Tau PET in Alzheimer disease and mild cognitive impairment.tau PET 显像在阿尔茨海默病及轻度认知障碍中的应用。
Neurology. 2016 Jul 26;87(4):375-83. doi: 10.1212/WNL.0000000000002892. Epub 2016 Jun 29.
6
Classification of patients with MCI and AD from healthy controls using directed graph measures of resting-state fMRI.使用静息态功能磁共振成像的有向图测量方法从健康对照中对轻度认知障碍和阿尔茨海默病患者进行分类。
Behav Brain Res. 2017 Mar 30;322(Pt B):339-350. doi: 10.1016/j.bbr.2016.06.043. Epub 2016 Jun 23.
7
In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.阿尔茨海默病谱系中 tau 和淀粉样蛋白的体内皮质扩散模式。
Ann Neurol. 2016 Aug;80(2):247-58. doi: 10.1002/ana.24711. Epub 2016 Jul 8.
8
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.候选 tau PET 配体 18F-AV-1451 的区域特征再现了 Braak 组织病理学分期的关键特征。
Brain. 2016 May;139(Pt 5):1539-50. doi: 10.1093/brain/aww023. Epub 2016 Mar 2.
9
Tau positron emission tomographic imaging in aging and early Alzheimer disease.衰老和早期阿尔茨海默病中的tau正电子发射断层成像
Ann Neurol. 2016 Jan;79(1):110-9. doi: 10.1002/ana.24546. Epub 2015 Dec 15.
10
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.在尸检脑组织上验证新型tau正电子发射断层显像示踪剂[F-18]-AV-1451(T807)
Ann Neurol. 2015 Nov;78(5):787-800. doi: 10.1002/ana.24517. Epub 2015 Sep 25.